Search

Your search keyword '"Isaev, Keren"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Isaev, Keren" Remove constraint Author: "Isaev, Keren"
48 results on '"Isaev, Keren"'

Search Results

1. Identification of genetic subtypes in follicular lymphoma

2. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.

3. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

4. Intertumoral Heterogeneity within Medulloblastoma Subgroups

7. Data from ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma

8. Supplementary Data from Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma

9. Table S2 from Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma

10. Identification of Genetic Subtypes in Follicular Lymphoma

11. Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

12. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

13. Combined burden and functional impact tests for cancer driver discovery using DriverPower

14. Integrative pathway enrichment analysis of multivariate omics data

15. Pathway and network analysis of more than 2500 whole cancer genomes

16. Divergent mutational processes distinguish hypoxic and normoxic tumours

17. Genomic footprints of activated telomere maintenance mechanisms in cancer

18. In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program

19. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

20. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas

21. Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma

22. Analyses of non-coding somatic drivers in 2,658cancer whole genomes

23. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

24. Pan-cancer analysis of whole genomes

25. Combined burden and functional impact tests for cancer driver discovery using DriverPower

26. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks

28. Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

29. ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma

30. Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes

31. Candidate cancer driver mutations in superenhancers and long-range chromatin interaction networks

32. Intertumoral Heterogeneity within Medulloblastoma Subgroups

34. CrebbpMutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

35. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-ASin gliomas

36. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

37. Sex differences in oncogenic mutational processes

38. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

39. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

40. Pan-cancer analysis of whole genomes

41. Sex differences in oncogenic mutational processes

42. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

43. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

44. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

45. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

46. Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox.

47. In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program.

48. Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.

Catalog

Books, media, physical & digital resources